BACKGROUND: Delays in follow-up after breast cancer screening contribute to disparities in breast cancer outcomes. The objective of this research was to determine the impact of race/ethnicity and health insurance on diagnostic time, defined as number of days from suspicious finding to diagnostic resolution. METHODS: This retrospective cohort study of 1538 women examined for breast abnormalities between 1998-2010 at 6 hospitals/clinics in the District of Columbia measured mean diagnostic times between non-Hispanic whites (NHWs), non-Hispanic blacks (NHBs), and Hispanics with private, government, or no health insurance by using a full-factorial ANOVA model. RESULTS: Respective average--geometric mean (95% CI)--diagnostic times (in days) for NHWs, NHBs, and Hispanics were 16 (12, 21), 27 (23, 33), and 51 (35, 76) among privately insured; 12 (7, 19), 39 (32, 48), and 71 (48, 105) among government insured; 45 (17, 120), 60 (39, 92), and 67 (56, 79) among uninsured. Government insured NHWs had significantly shorter diagnostic times than government insured NHBs (P = .0003) and Hispanics (P < .0001). Privately insured NHWs had significantly shorter diagnostic times than privately insured NHBs (P = .03) and Hispanics (P < .0001). Privately insured NHBs had significantly shorter diagnostic times than uninsured NHBs (P = .03). CONCLUSIONS: Insured minorities waited >2 times longer to reach their diagnostic resolution than insured NHWs. Having private health insurance increased the speed of diagnostic resolution in NHBs; however, their diagnostic time remained significantly longer than for privately insured NHWs. These results suggest diagnostic delays in minorities are more likely caused by other barriers associated with race/ethnicity than by insurance status.
BACKGROUND: Delays in follow-up after breast cancer screening contribute to disparities in breast cancer outcomes. The objective of this research was to determine the impact of race/ethnicity and health insurance on diagnostic time, defined as number of days from suspicious finding to diagnostic resolution. METHODS: This retrospective cohort study of 1538 women examined for breast abnormalities between 1998-2010 at 6 hospitals/clinics in the District of Columbia measured mean diagnostic times between non-Hispanic whites (NHWs), non-Hispanic blacks (NHBs), and Hispanics with private, government, or no health insurance by using a full-factorial ANOVA model. RESULTS: Respective average--geometric mean (95% CI)--diagnostic times (in days) for NHWs, NHBs, and Hispanics were 16 (12, 21), 27 (23, 33), and 51 (35, 76) among privately insured; 12 (7, 19), 39 (32, 48), and 71 (48, 105) among government insured; 45 (17, 120), 60 (39, 92), and 67 (56, 79) among uninsured. Government insured NHWs had significantly shorter diagnostic times than government insured NHBs (P = .0003) and Hispanics (P < .0001). Privately insured NHWs had significantly shorter diagnostic times than privately insured NHBs (P = .03) and Hispanics (P < .0001). Privately insured NHBs had significantly shorter diagnostic times than uninsured NHBs (P = .03). CONCLUSIONS: Insured minorities waited >2 times longer to reach their diagnostic resolution than insured NHWs. Having private health insurance increased the speed of diagnostic resolution in NHBs; however, their diagnostic time remained significantly longer than for privately insured NHWs. These results suggest diagnostic delays in minorities are more likely caused by other barriers associated with race/ethnicity than by insurance status.
Authors: R G Roetzheim; N Pal; C Tennant; L Voti; J Z Ayanian; A Schwabe; J P Krischer Journal: J Natl Cancer Inst Date: 1999-08-18 Impact factor: 13.506
Authors: Sherry R Crump; Michèle P-L Shipp; Gail G McCray; Selma J Morris; Joel A Okoli; Lee S Caplan; Stacy L Thorne; Daniel S Blumenthal Journal: Health Promot Pract Date: 2008-04
Authors: Louise J Short; Maxine D Fisher; Peter M Wahl; Monique B Kelly; Grant D Lawless; Sandra White; Nancy A Rodriguez; Vincent J Willey; Otis W Brawley Journal: Cancer Date: 2010-01-01 Impact factor: 6.860
Authors: Sasha A McGee; Danielle D Durham; Chiu-Kit Tse; Robert C Millikan Journal: Cancer Epidemiol Biomarkers Prev Date: 2013-07 Impact factor: 4.254
Authors: Danielle D Durham; Whitney R Robinson; Sheila S Lee; Stephanie B Wheeler; Katherine E Reeder-Hayes; J Michael Bowling; Andrew F Olshan; Louise M Henderson Journal: Cancer Epidemiol Biomarkers Prev Date: 2016-11 Impact factor: 4.254
Authors: Angie Mae Rodday; Susan K Parsons; Frederick Snyder; Melissa A Simon; Adana A M Llanos; Victoria Warren-Mears; Donald Dudley; Ji-Hyun Lee; Steven R Patierno; Talar W Markossian; Mechelle Sanders; Elizabeth M Whitley; Karen M Freund Journal: Cancer Date: 2015-09-08 Impact factor: 6.860
Authors: Jill K Schinkel; Shelia Hoar Zahm; Ismail Jatoi; Katherine A McGlynn; Christopher Gallagher; Catherine Schairer; Craig D Shriver; Kangmin Zhu Journal: Cancer Causes Control Date: 2014-05-17 Impact factor: 2.506
Authors: Alexi A Wright; Heather Stieglitz; Yankel M Kupersztoch; M Elizabeth Paulk; Yookyung Kim; Ingrid T Katz; Francisco Munoz; Rachel B Jimenez; Jan Mutchler; Lorna Rivera; Anthony L Back; Holly G Prigerson Journal: PLoS One Date: 2013-03-11 Impact factor: 3.240